CN1050753C - wound healing agent - Google Patents
wound healing agent Download PDFInfo
- Publication number
- CN1050753C CN1050753C CN93104920A CN93104920A CN1050753C CN 1050753 C CN1050753 C CN 1050753C CN 93104920 A CN93104920 A CN 93104920A CN 93104920 A CN93104920 A CN 93104920A CN 1050753 C CN1050753 C CN 1050753C
- Authority
- CN
- China
- Prior art keywords
- wound healing
- wounds
- healing agent
- present
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003357 wound healing promoting agent Substances 0.000 title abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims description 6
- 235000013705 Vitis romanetii Nutrition 0.000 claims 1
- 241000707167 Vitis romanetii Species 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 23
- 208000027418 Wounds and injury Diseases 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 9
- 235000017190 Vitis vinifera subsp sylvestris Nutrition 0.000 abstract description 6
- 244000237969 Vitis vulpina Species 0.000 abstract description 6
- 235000017242 Vitis vulpina Nutrition 0.000 abstract description 6
- 244000294611 Punica granatum Species 0.000 abstract description 5
- 235000014360 Punica granatum Nutrition 0.000 abstract description 5
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 abstract description 3
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract description 3
- 241001071917 Lithospermum Species 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 206010053615 Thermal burn Diseases 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 238000002791 soaking Methods 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 235000005865 Symphytum officinale Nutrition 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 244000132619 red sage Species 0.000 description 4
- 210000003371 toe Anatomy 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 244000292697 Polygonum aviculare Species 0.000 description 3
- 235000006386 Polygonum aviculare Nutrition 0.000 description 3
- 241001442052 Symphytum Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000978499 Brunnichia ovata Species 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 206010046914 Vaginal infection Diseases 0.000 description 2
- 201000008100 Vaginitis Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 206010039083 rhinitis Diseases 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 230000008470 skin growth Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 206010008685 Chondritis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229940115939 shigella sonnei Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本发明涉及一种有含有细菌性抗原的医药制品,特别是一种将中草药放在药用乙醇中浸泡,提炼其有效成份精制而成的创口愈合剂。The invention relates to a pharmaceutical product containing bacterial antigens, in particular to a wound healing agent obtained by soaking Chinese herbal medicine in medicinal ethanol and extracting its active ingredients.
目前,西医对创口医疗一般采用常规消毒后敷以利凡诺(RIV-ANOLUM)‰浸液纱布或纱布条塞入创口内,有的也采用抗生素软膏、硼酸软膏或鱼石脂软膏、消肿止痛等药物治疗,主要视不同创口性质而定,但对于受结核杆菌或金黄色葡萄球菌侵袭引起的顽固性创口,如结核性瘘管、下肢溃疡大面积创口等,采用西药外科药物外敷或药纱条内塞,很难达到理想疗效,而且疗效慢。At present, Western medicine generally adopts routine disinfection for wound treatment and then applies RIV-ANOLUM ‰ soaked gauze or gauze strips into the wound, and some also use antibiotic ointment, boric acid ointment or ichthyol ointment to reduce swelling and relieve pain, etc. Drug treatment mainly depends on the nature of different wounds, but for refractory wounds caused by Mycobacterium tuberculosis or Staphylococcus aureus, such as tuberculous fistula, large-area wounds of lower extremity ulcers, external application of western medicine surgical drugs or internal medicine gauze Blockage, it is difficult to achieve the desired curative effect, and the curative effect is slow.
由浙江省中医协会主办的《中医报》1986年第13期上介绍了一味治疗骨髓炎的临床报道,它用野葡萄根煎剂口服,并将其浸出液浸纱条外治骨髓炎,其不足之处:1.由于顽固性创口大多发生在阴湿或缺乏肌肉部位,用单味野葡萄根浸液浸纱条进行治疗对创口收敛慢;2.用于治疗对其它细菌如结核杆菌侵袭引起的创口效果差。On the 13th issue of 1986, the "Chinese Medicine News" sponsored by Zhejiang Association of Traditional Chinese Medicine introduced a clinical report on blindly treating osteomyelitis. Advantages: 1. Since most of the intractable wounds occur in wet or lacking muscles, soaking gauze strips with single-flavored wild grape root extract will slow the convergence of the wounds; 2. It is used to treat other bacteria such as Mycobacterium tuberculosis. The wound effect is poor.
由于上述实际情况,往往使顽固性创口迁延时间终成痼疾。Due to the above-mentioned actual situation, the protracted time of the intractable wound often becomes a chronic disease eventually.
本发明的目的是提供一种用于治疗多种顽固性刨口而且疗效快速的创口愈合剂。The purpose of the present invention is to provide a kind of wound healing agent which is used for treating various obstinate cuts and has fast curative effect.
为了达到上述目的,本发明采用由下述重量配比原料药物制成的药剂进行解决:将紫草5%-20%、红藤5%-20%、虎杖10%-40%、野葡萄根10%-40%、丹参10%-40%、石榴皮2%-20%组成的中草药一起浸泡制成,提炼其有效成份精制而成,其制剂成为一种治疗顽固性创口的创口愈合剂。In order to achieve the above object, the present invention adopts the medicament that is made of the following raw materials by weight ratio to solve the problem: comfrey 5%-20%, red vine 5%-20%, Polygonum cuspidatum 10%-40%, wild grape root 10%-40%, salvia miltiorrhiza 10%-40%, pomegranate peel 2%-20% are made by soaking Chinese herbal medicine together, extracting its active ingredients and refining, and its preparation becomes a wound healing agent for treating stubborn wounds.
本发明将野葡萄根、紫草、红藤、虎杖放在药用乙醇进行浸泡,提炼、精制而成,其制剂中的有效成份对各种细菌有广谱的抗菌作用;对金黄色葡萄菌极度敏感,对白色葡萄球菌、绿脓杆菌、脑膜炎球菌、伤寒杆菌、卡他球菌、甲型链球菌、福氏及宋氏痢疾杆菌,结核杆菌有抑菌作用,因此它能够用于治疗各种细菌侵袭引起的顽固性创口。本发明还采用了丹参、石榴皮中草药,因此,本发明还具有消肿、活血、收敛、生肌、促进新皮生长和骨骼再生的功能,特别对于治疗发生在阴湿或缺乏肌肉部位的顽固性创口,具有创口收敛快的特点。由于本发明的制剂中含有以上所述的中草药的有效成份,它们协同作用,加快了治愈的速度。本发明用于临床治疗210例,治愈率达100%。The present invention soaks wild grape roots, comfrey, red vine, and knotweed in medicinal ethanol, extracts and refines them. The active ingredients in the preparation have broad-spectrum antibacterial effects on various bacteria; Extremely sensitive, it has antibacterial effect on Staphylococcus albus, Pseudomonas aeruginosa, meningococcus, typhoid bacillus, catarrhal coccus, streptococcus flexneri and Shigella sonnei, tubercle bacillus, so it can be used to treat various Refractory wounds caused by a bacterial attack. The present invention also adopts Danshen and pomegranate peel Chinese herbal medicines. Therefore, the present invention also has the functions of reducing swelling, invigorating blood circulation, astringent, promoting muscle growth, promoting new skin growth and bone regeneration, especially for the treatment of recalcitrant diseases occurring in dampness or lack of muscle. Sexual wounds have the characteristics of rapid wound convergence. Because the preparation of the present invention contains the active ingredients of the above-mentioned Chinese herbal medicines, they act synergistically to speed up the healing process. The present invention is used for clinical treatment of 210 cases, and the cure rate reaches 100%.
本发明与已有技术相比具有如下优点:Compared with the prior art, the present invention has the following advantages:
1.有广谱的抗菌作用。1. It has broad-spectrum antibacterial effect.
2.由于本发明收湿性极强,不但能治疗暴露创口例如下肢溃疡、单纯性或带状泡疹、疖、疡、疽之创口,而且还能用于治疗阴湿部分渗出液特别多的湿浓性炎症,例如鼻炎症、颈部湿疹、中内耳炎(包括内耳结核性软骨炎)、腋下湿疹、阴囊湿疹、阴道炎、宫颈糜烂、肛门湿疹等多种疾病。2. Due to the extremely strong hygroscopicity of the present invention, it can not only treat exposed wounds such as lower extremity ulcers, simple or herpes zoster, furuncles, ulcers, and gangrene wounds, but also be used to treat yin and damp parts with a lot of exudate Concentrated inflammation, such as rhinitis, neck eczema, otitis media (including tuberculous chondritis of the inner ear), axillary eczema, scrotum eczema, vaginitis, cervical erosion, anal eczema and other diseases.
3.由于本发明采用了中草药浸泡精制而成的制剂,因此,它使用时能够采用西医的纱布块或纱布条浸液外敷或内塞治疗方法。3. Because the present invention has adopted the preparation that Chinese herbal medicine soaks and refines, therefore, can adopt the gauze block or gauze strip soaking liquid external application of western medicine or the treatment method of inner plug when it uses.
4.由于本发明收湿性强,又含有胶质,当制剂浸纱布多层,作为骨折药外敷时,干燥后紧贴创口或骨折部,能起到类似石膏绷带特有的固定作用。4. Because the present invention has strong hygroscopicity and contains colloid, when the preparation is soaked in multiple layers of gauze and applied externally as a fracture medicine, it will stick to the wound or fracture after drying, and can play a unique fixing effect similar to a plaster bandage.
5.由于本发明具有活血、生肌、促进新皮生长和骨骼生长的作用,对断指(趾)再殖和断指(趾)残段保留手术有特殊疗效。5. Because the present invention has the effects of invigorating blood circulation, promoting granulation, and promoting new skin growth and bone growth, it has special curative effects on the repopulation of amputated fingers (toes) and the operation of retaining the stumps of amputated fingers (toes).
6.对烫伤尚未破溃的新创面本发明有特殊疗效。6. The present invention has a special curative effect on fresh wounds that have not yet been ulcerated.
7.可取代利凡诺(RIVANOLUM)。7. Can replace Rivanol (RIVANOLUM).
下面结合实施例对本发明作进一步详细说明。The present invention is described in further detail below in conjunction with embodiment.
本发明将紫草、红滕、虎杖、野葡萄根、丹参、石榴皮六种成份按表1所示比例配成的中草药,放在药用乙醇中浸泡,浸泡一段时间后,提炼其有效成份精制而成,其制剂成为一种治疗多种顽固性创口的创口愈合剂。用该创口愈合剂采用纱布块或布条浸液外敷或内塞治疗方法用于临床治疗情况见表2。In the present invention, the Chinese herbal medicine made from six components of comfrey, red teng, knotweed, wild grape root, salvia miltiorrhiza, and pomegranate peel according to the ratio shown in Table 1 is soaked in medicinal ethanol, and after soaking for a period of time, its active ingredients are extracted Refined, its formulation becomes a wound-healing agent for a variety of recalcitrant wounds. See Table 2 for clinical treatment using the wound healing agent for external application or internal plugging of gauze pieces or strips of soaking liquid.
本发明各实施例的中草药成分配比(以总重量1kg计)The Chinese herbal medicine composition proportion (in total weight 1kg) of each embodiment of the present invention
表1
表2
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93104920A CN1050753C (en) | 1993-05-05 | 1993-05-05 | wound healing agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93104920A CN1050753C (en) | 1993-05-05 | 1993-05-05 | wound healing agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1082912A CN1082912A (en) | 1994-03-02 |
| CN1050753C true CN1050753C (en) | 2000-03-29 |
Family
ID=4985464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93104920A Expired - Fee Related CN1050753C (en) | 1993-05-05 | 1993-05-05 | wound healing agent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1050753C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055144A (en) * | 2012-12-28 | 2013-04-24 | 青岛爱维互动信息技术有限公司 | Patch for treating skin wounds |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1017299B (en) * | 1988-12-23 | 1992-07-01 | 松下电器产业株式会社 | Video tape recorder with TV system converter |
-
1993
- 1993-05-05 CN CN93104920A patent/CN1050753C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1017299B (en) * | 1988-12-23 | 1992-07-01 | 松下电器产业株式会社 | Video tape recorder with TV system converter |
Non-Patent Citations (3)
| Title |
|---|
| 《四川中医》1988,6(10) 1988.10.31 张陈炎,野葡萄考 * |
| 《河南中医》1986,(5) 1986.5.31 贾北平,郑州医药专修学校 * |
| 《药学通报》1987,22(4) 1987.4.30 冯世栋,浙江鄞县人民医院 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1082912A (en) | 1994-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101310748B (en) | Ointment for treating empyrosis | |
| CN113413375A (en) | External-use medicine composition for treating various wound surfaces of skin and preparation method thereof | |
| CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
| CN101732591B (en) | Sores plaster | |
| CN1176709C (en) | Drug for curing scald, hrut and inflammations as well as hemorrhoids | |
| CN1050753C (en) | wound healing agent | |
| CN102727698B (en) | Wound surface nursing powder for treating bedsore | |
| CN102688368B (en) | Traditional Chinese medicine for treating trauma hemostasis or telephium | |
| CN1072499C (en) | External-use medicine for curing various chronic ulcers | |
| CN111544514A (en) | A Chinese medicinal ointment for treating burn and scald, and its preparation method | |
| CN106728069B (en) | Slough-removing and tissue regeneration-promoting paste for treating scalds and burns | |
| CN104623443A (en) | Traditional Chinese medicine for treating skin erosion | |
| CN104161961B (en) | The Chinese medicine for outer use for the treatment of diabetic foot ulcer, preparation method and applications | |
| CN104689075B (en) | Chinese and western medicine combined medicine for treating pressure sores | |
| CN1097316A (en) | The prescription and the production technology of one group of burn Chinese medicine | |
| CN1062761C (en) | Multifunctional pain-relieving liquid and its preparation method | |
| CN1103791A (en) | Sprinkling agent for burns and the process for prepn. of same | |
| CN110882270B (en) | Pharmaceutical composition containing silicon-based regenerative medical material and preparation method thereof | |
| CN109331106B (en) | Red medicine preparation for wound repair and preparation method thereof | |
| CN103655745B (en) | A kind of pharmaceutical composition for the treatment of burn and scald | |
| CN108355130A (en) | It is a kind of to treat psoriasic temperature sensitive type collagen composite antiphlogistic gel spray and preparation method thereof | |
| CN105560343A (en) | Traditional Chinese medicine composition for treating neonatal omphalitis | |
| CN108245577B (en) | Ointment for relieving pain, eliminating swelling and promoting tissue regeneration of burn and preparation method thereof | |
| CN1439400A (en) | Spray for burn and scald and preparation thereof | |
| CN104971162A (en) | Ointment for treating burn and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |